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Abstract
Retinoic acid (RA) is a morphogen derived from retinol (vitamin A) that plays important roles in cell growth,
differentiation, and organogenesis. The production of RA from retinol requires two consecutive enzymatic reactions
catalyzed by different sets of dehydrogenases. The retinol is first oxidized into retinal, which is then oxidized into
RA. The RA interacts with retinoic acid receptor (RAR) and retinoic acid X receptor (RXR) which then regulate the
target gene expression. In this review, we have discussed the metabolism of RA and the important components of
RA signaling pathway, and highlighted current understanding of the functions of RA during early embryonic
development.
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Introduction
Retinoids refer to those chemicals that are structurally
or functionally similar to retinol, or vitamin A [1],
which is an essential biomolecule for embryonic devel-
opment and adult body homeostasis. All retinoids retain
the polyene hydrophobic tail attached to a cyclic 6-car-
bon ring. The polyene tail is characterized by the alter-
nating conjugated carbon-carbon double bonds, which
makes retinoids light-sensitive. In contrast with other
signaling proteins, retinoids have a much lower molecu-
lar weight of approximately 300 Da. Given their molecu-
lar structures, retinoids are highly oil-soluble and able to
diffuse across the cell membrane. Retinoids are involved
in cellular growth, apoptosis, immune response, and
epithelial growth [2-7] through the interaction with the
nuclear receptors, retinoic acid receptor (RAR) and reti-
noid X receptor (RXR). During early embryonic develop-
ment, the major active form of retinoids, all-trans
retinoic acid (atRA), regulates germ layer formation,
body axis formation, neurogenesis, cardiogenesis, and
the development of pancreas, lung, and eye. It is also a
critical element for visual function [8]. Because of the
wide spectrum of RA functions, the metabolism,
regulation, and function of vitamin A have been exten-
sively studied for decades, and here we summarize our
current understanding on retinoids metabolic pathways
and RA functions during early embryonic development.
2. Metabolism of vitamin A and the production of
all-trans retinoic acid
Vitamin A is a necessary dietary vitamin for the normal
development and vision. The critical necessity of vitamin
A was hinted as early as 1881 by Nikolai Lunin, who dis-
covered that purified protein, fat, and carbohydrate did not
sustain the normal growth of mice, unless the diet was
supplemented with milk. Elmer Verner McCollum, then
determined in 1917 that the critical component concerned
in milk was actually a “fat-soluble factor A”, named in con-
trast to the previously discovered “water-soluble factor B”,
or vitamin B. These discoveries allowed Carl Edvard Bloch,
a Denmark paediatrician, to identify vitamin A deficiency
as the cause of night blindness, or xerophthalmia [9].
While vitamin A was a necessary dietary vitamin, vita-
min A itself is not the main bioactive mediator of its
function. The key mediators of vitamin A function were
identified as atRA and 11-cis retinal. atRA is a regulator
of gene transcription, while 11-cis retinal acts as a chro-
mophore for visual functions [10]. In this section, we
will review the metabolic processes of converting vita-
min A into various retinoids, with emphasis on the pro-
duction of atRA (Figure 1).
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2.1 Conversion of Vitamin A (atROL) to all-trans retinal
(atRAL)
Vitamin A (hereby referred to as all-trans retinol,
atROL) is absorbed in the small intestine and esterified
as retinyl esters for the blood stream transport. Retinyl
ester is first transported to the liver for storage, mainly
in the hepatic stellate cell. Hydrolysis of retinyl esters
results in retinol, which then binds to retinol binding
protein (RBP). The atROL/RBP complex is the dominant
form for systematical and intercellular transport. After
target organs take up the atROL/RBP complex, the
atROL either is re-esterified into retinyl ester by lecithin
retinol acyltransferase (LRAT) or binds to cellular reti-
nol-binding protein (CRBP). The CRBP can prevent
intracellular atROL from non-specific oxidation, immo-
bilize intracellular retinol for storage, and acts as a car-
rier protein to present the atROL to respective retinol
dehydrogenase for oxidation, or to LRAT for esterifica-
tion [11]. Thus, the esterification by LRAT and/or the
binding to CRBP represent the most upstream regula-
tion of atROL availability, and therefore atRA metabo-
lism, in the cell [12].
Retinyl ester and CRBP-bound retinol are the main
storage forms of atROL. The retinyl ester can be hydro-
lyzed into 11-cis retinol by isomerohydrolases [13,14].
The cellular retinaldehyde binding protein (CRALBP)
binds to 11-cis retinol with high affinity [15], which
leads to the oxidation of 11-cis retinol to 11-cis retinal
by 11-cis retinol dehydrogenase [16,17]. The 11-cis ret-
inal is an essential component for vision. It binds to
opsin to form rhodopsin, which can absorb lights within
the visible spectrum. When the 11-cis-retinal absorbs a
photon, it isomerizes from the 11-cis state to atRAL.
The binding of atRAL to opsin is not stable and atRAL
is rapidly released from opsin. Such molecule move-
ments cause cell membrane change, and eventually lead
to generation of the nerve impulse for vision (Figure 1).
atROL/CRBP complexes are the first substrate in the
metabolic pathway which leads to the production of
atRA. Using atROL/CRBP as substrate, retinol dehydro-
genase (RDH), which belongs to short-chain dehydro-
genase/reductase (SDR) family, catalyzes the oxidation
of atROL to all-trans retinal (atRAL) [18]. This step is
the rate limiting step in the production of atRA [19]. It
has also been demonstrated that in vitro free atROL can
be converted into atRAL by non-specific enzymes
including alcohol dehydrogenase [20]. CRBP therefore
provides a selection mechanism for specific RDH-
mediated oxidation of atROL. Indeed, RDH has a much
higher affinity towards atROL/CRBP complex than free
atROL and the reaction depends on protein-protein
interaction between RDH and CRBP [21]. It has been
demonstrated that the microsomal RDH interacts with
atROL/CRBP-I in the presence of co-factor, nicotina-
mide adenine dinucleotide phosphate (NADP) [22].
Moreover, atROL/CRBP is the preferred substrate for
the retinol dehydrogenase 16 (RDH16. Abbreviated as
RoDH-4 in the original article), but not for 3a-hydro-
xysteroid dehydrogenase (3a-HSD), a similar alcohol
dehydrogenase which has an even higher affinity
towards free atROL [23]. Thus, CRBP acts as a selection
protein for RDH by increasing the substrate affinity for
RDH, which in turn prevents non-specific oxidation of
atROL by alcohol dehydrogenase.
The conversion of atROL to atRAL is, in fact, reversible.
The direction - oxidation or reduction - favored by differ-
ent members of SDR family depends on the substrate affi-
nity, co-factor affinity, and the rate of reaction. In addition
to CRBP that contributes to substrate affinity, another fac-
tor that contributes to substrate affinity is the intrinsic
substrate binding site on the SDR family of enzymes. Ret-
inal reductase 1 (RalR1), a human SDR, has been shown to
be reactive towards both atROL and atRAL in vitro. How-
ever, RalR1 has a higher affinity and rate of reduction for
atRAL than atROL, indicating that RalR1 is a retinal
reductase, rather than retinol dehydrogenase, under phy-
siological conditions [24]. Co-factor affinity of different
SDR has also been demonstrated that the co-factor
favored by SDR reflects the direction of reaction catalyzed
by that particular SDR (reviewed by Pares) [25].
Apart from RalR1, a number of retinal reductases have
been identified in the past decades. A human short-
Figure 1 Schematic diagram showing the metabolic pathways
of vitamin A metabolism. This illustration lists the major steps of
RA metabolism in cell, please refer to the text for details.
Abbreviation: NAD, nicotinamide adenine dinucleotide; NADH, The
reduced form of NAD; NADP, nicotinamide adenine dinucleotide
phosphate; NADPH, The reduced form of NADP; CRBP: cellular
retinol-binding protein; LRAT: lecithin retinol acyltransferase; REH:
retinyl ester hydrolase; ADH: alcohol dehydrogenase; RDH: retinol
dehydrogenase; SDR: short-chain dehydrogenase/reductases; ALDH:
aldehyde dehydrogenase; RALDH: retinaldehyde dehydrogenase.
CRAD: cis-retinoid/androgen dehydrogenase. Modified from [18,25].
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chained retinol reductase (retSDR1) identified in a neu-
roblastoma cell line has been shown to promote the for-
mation of retinyl ester in the presence of exogenous
atRAL [26]. A mouse liver peroxisomal SDR termed
mouse retinal reductase (RRD) also showed a high
atRAL-specific reductase activity in the presence of
CRBP in vitro [27]. This enzyme was induced by peroxi-
some proliferator-activated receptor (PPAR), suggesting
a relationship between retinoid metabolism and peroxi-
some activity [27]. Using in vitro assay, some studies
have identified reductases which showed in vitro retinal-
reducing activity. For example, human aldose reductase
and human small intestine aldose reductase can function
as retinal reductase in vitro [28]. Similarly, the mouse
short-chained aldehyde reductase (SCALD) could reduce
atRAL and 9-cis retinal in vitro [29]. However, these stu-
dies are based on in vitro biochemical analysis only and
do not take into account the substrate selection by
CRBP. Therefore, the enzymatic activities on different
retinal reported should not be taken as a direct evidence
for physiological retinal reductases.
2.2 Conversion of atRAL to atRA
Similar to atROL, all-trans retinal is also transported by
CRBP in the cell, and is then oxidized to atRA. The oxi-
dation from atRAL to atRA has been observed as early
as 1960 [30]. The oxidation of atRAL to atRA was
mediated by various retinaldehyde dehydrogenases
(RALDH). At least 3 RALDHs have been identified in
human, mouse, and Xenopus, with different physiologi-
cal functions [31]. Retinaldehyde dehydrogenase 1
(Raldh1) is highly expressed in the dorsal retina of
mouse embryos [32], in epithelial tissues of adult mice
and Xenopus [33], and in the stomach and small intes-
tine of adult rats [34]. Xenopus raldh1 has been shown
to be an atRA synthesizing enzyme in a retinoic acid
responsive cell line [35]. RALDH1-/-mice also suggest
that Raldh1 is capable of atRA synthesis [36]. However,
knockout of RALDH1 did not severely affect the mor-
phology of the retina although RALDH1 is localized in
the dorsal retina [36], indicating that other enzymes
might redundantly share the function of RALDH1.
The retinaldehyde dehydrogenase 2 (RALDH2) was
identified in human, mouse, chick, zebrafish and Xenopus
[37-39]. Interestingly, RALDH2 was identified as a crucial
enzyme for atRA synthesis in different organisms. Knock-
out of RALDH2 was embryonic lethal during the post-
implantation period in mice [40], suggesting that atRA is
essential for normal embryonic development. The pheno-
types of RALDH2 knock-out mice include severely
impaired segmentation of rhombomeres, altered homeo-
box gene expression pattern, and defective neural crest
cell migration [41]. In zebrafish, knockdown of raldh2
caused a down-regulation of retinoic acid signaling,
malformation in the central nervous system, and disrup-
tion of left-right asymmetry [42,43]. The raldh2 mutant,
neckless (nls), displayed a suppressed formation of the
midbrain to hindbrain region, as well as segmentation
defects in rhombomeres [44]. Such defects were attributed
to the reduction in atRA signaling [45], since the spatial
and temporal pattern of atRA signaling is maintained
mainly by raldh2 and a degradative enzyme cytochrome
P450 hydroxylase A1 (cyp26a1) in zebrafish. In Xenopus
embryos, ectopic expression of raldh2 caused teratogenic
effects such as the expression of posterior neural markers
(en2 and krox20) in the anterior region, which is similar to
that due to atRA toxicity [38], suggesting that raldh2 is an
important enzyme in maintaining atRA homeostasis in
embryos. Knockdown of raldh2 in Xenopus embryos
caused a shortening of anteroposterior axis and a posterior
shift of neural marker en2 and krox20 [46]. Collectively,
such evidence indicated that raldh2 plays a crucial role in
the anteroposterior patterning of the central nervous sys-
tem and trunk axis through regulation of the RA signaling.
Retinaldehyde dehydrogenase 3 (RALDH3) has been
identified in human, chick, mouse, zebrafish, and Xeno-
pus, and is expressed in the ventral retina across various
species [47-51]. Studies in mouse have shown that
RALDH3 was mainly involved in the frontonasal devel-
opment and patterning of ocular structures [52]. Mice
lacking RALDH3 were neonatal lethal, due to the
respiratory tract obstruction in nasal region, and the
neonatal lethality could be rescued by atRA supplements
[53], suggesting that RALDH3 is an atRA synthesis
enzyme. In 2007, Halilagic et al. showed that atRA pro-
duction by RALDH3 contributed to the correct pattern-
ing of the anterior and dorsal boundaries of the
developing forebrain [54]. It was further delineated that
RALDH3 knockout mice exhibited loss of dopamine
receptor D2 in the ventral forebrain. These studies sug-
gest that RALDH3 is essential for the development of
the central nervous system and the morphogenesis of
anterior head structures [52].
Similar to atROL and atRAL, the metabolism of atRA
is also closely related to retinoid binding protein termed
cellular retinoic acid binding proteins (CRABPs).
CRABPs bind to intracellular RA and prevent it from
non-specific degradation [55,56]. There are two species
of CRABP, CRABP-I and CRABP-II. These carrier pro-
teins also ensure the solubility of hydrophobic retinoid
in the aqueous intracellular environment. However, a
recent study of CRBP-I/CRABP-I/CRABP-II triple
knock-out mice has shown that the main regulator of
retinoid homeostasis was likely to be CRBPs, with
CRABPs playing a minor role in this process. Hoegberg
et al. found that the chemical-induced depletion of total
retinoids in triple knockout mice was more severe than
the wild type and CRABP-I/CRABP-II double knockout
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mice [57], suggesting that CRBP-I is a more potent reg-
ulator of retinoid homeostasis. While CRABPs might
not be critical in regulating total retinoids homeostasis,
they participate in mediating RA signaling by transport-
ing RA to the nucleus to interact with RARs. CRABP-II
was shown to be translocated into nucleus upon the
ligand binding [58], which allows atRA to bind to and
activate RAR, a transcription factor responsible for the
RA signaling (Figure 2). Interestingly, the RA signaling
is tightly regulated by negative feedback mechanisms as
CRABP-II is negatively regulated by atRA [59]. Elevated
RA signaling suppresses the production of CRABPs,
which down-regulate the activation of RARs and the RA
signaling. CRABP-I, on the other hand, regulates the
rate of RA metabolism by presenting RA to the degrad-
ing enzyme CYP26A1 [60].
2.3 Degradation of atRA
All-trans retinoic acid is degraded by CYP26 enzymes,
which belong to cytochrome P450 hydroxylase family. A
number of CYP26 family including CYP26A1, B1, C1,
and D1 have been characterized and all of them possess
the ability to degrade atRA into less bio-active retinoid
[61-63]. Rhombomeric alteration defects were only
observed by the knockdown of all three cyp26 enzymes
in zebrafish [64], suggesting that cyp26a1, b1 and c1 act
redundantly in hindbrain patterning. CYP26A1 is
induced by atRA while it promotes the hydroxylation of
atRA into 4-hydroxy retinoic acid, 4-oxo retinoic acid,
and 18-hyroxy retinoic acid [45,65-67]. Since RALDH2
and CYP26A1 are both regulated by atRA itself, the
metabolism of atRA therefore forms an auto-regulatory
loop that regulates and balances atRA levels in embryos.
Such regulation not only maintains the endogenous
atRA level within a normal range, but also allows the
organisms to respond to exogenous atRA fluctuation.
3. Retinoic acid receptors
atRA is carried into the nucleus by CRABP-II, and inter-
acts with RARs, which themselves are transcription
Figure 2 Ilustration of RA and paracrine RA signaling. In serum, retinol is bound to retinol-binding protein 4 (RBP-4) synthesized in the liver.
Although retinol is lipid soluble, it enters cells mainly through the interaction with its receptor STRA. In the cell, retinol can either be converted
into retinyl esters for storage via lecithin retinol acyltransferase (LRAT) or bind to the cellular retinol binding protein (CRBP). The CRBP-bound
retinol is oxidized to retinal by either alcohol dehydrogenase (ADH) or retinol dehydrogenase (RDH), and retinal is oxidized to retinoic acid (RA)
by retinaldehyde dehydrogenases (RALDH1/2/3). All-trans retinoic acid (atRA) is the major bioactive component among the retinoids. CYP26 can
further oxidize atRA to 4-oxo-RA for degradation. Cellular retinoic acid-binding protein (CRABP) facilitates transportation of atRA into the nucleus
where atRA binds its receptors. The ternary complex of ligand-bound RAR and RXR binds to the retinoic acid response element (RARE) and
activates the RA target genes. atRA can diffuse to adjacent cells to activate target gene expression in these cells. RAR can also bind to the liver X
receptor (LXR), farnesoid X receptor (FXR), and peroxisome proliferator-activated receptor (PPAR) for multiple functions.
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factors. RARs belong to retinoid receptor family, which
also includes another group called retinoid X receptors
(RXRs). RARs recognize both atRA and 9-cis retinoic
acid, while RXRs only recognize 9-cis retinoic acid.
Upon the ligand binding, RAR dimerizes with RXR to
form a heterodimer, which then initiate gene transcrip-
tion by binding to the retinoic acid response element
(RARE) in the promoter region of the targets genes (Fig-
ure 2). The RAR family consists of RARa/b/g three
members that bind to atRA [68-71]. Single knockout
mice that lack each of RARs were not embryonic lethal
and did not display the complete spectrum of vitamin A
deficiency phenotype. A disruption in RARa did not
cause any observable phenotypic change in a mouse
model [72]. Knockout of RARb caused a reduction in
the body weight and ocular defect, while limb formation
remained normal [73]. Double knockout of two RARg
subtypes caused growth deficiency, cartilage dysmorpho-
genesis, and vertebrate malformation [74]. These results
imply that RARs work redundantly and compensate the
function of each other. Indeed, knockdown of RARa
caused an increase in the expression level of RARb and
RARg [75]. Only double knockout mutants showed phe-
notype close to the symptoms of vitamin A deficiency
[76]. The auto-regulatory loop of RAR expression is
similar to that regulating the expression of of RALDH2
and CYP26a1. Moreover, RARE has been identified in
the promoter regions of RARa and b [77-79], indicating
that the expression of these RARs is also under control
of atRA.
Similarly, there are also three subtypes of RXRs [80].
RXRa knockout mice were embryonic lethal, potentially
due to malformation of the heart in utero [81]. RXRb
knockout mice were 50% embryonic lethal, and the sur-
viving littermates were morphologically normal except
spermatogenesis defects which rendered the male sterile
[82], while the RXRg-null mutant mice were morpholo-
gically normal when compared with the wild type [83].
Moreover, the mice carrying only one copy of RXRa
(RXRa+/-/RXRb-/-/RXRg-/-) were viable, suggesting
one copy of RXRa is sufficient to carry out most of
function of the RXRs [83]. Since atRA-bound RAR can
form heterodimer with RXR in the absence of 9-cis reti-
noic acid and is still active in transcription activities, the
importance of RXRs may not be as critical as RARs.
This may explain why only one copy of RXRa is suffi-
cient for the mouse embryonic development. Taken
together, these results suggest that each of the RAR sub-
types function redundantly and most of the RXR sub-
types are not critical for the embryonic development.
While RARs mainly mediate the RA signaling, it has
been revealed by many studies that ligand-bound RXRs
activate other signaling pathways by forming heterodi-
mer with other nuclear receptors such as liver X
receptor (LXR), farnesoid X receptor (FXR), and PPAR
[84-86] (Figure 2). LXR mainly functions as a sensor of
cholesterol levels by recognizing its ligand oxysterols.
Overloading cells with cholesterol activates LXR/RXR
heterodimers which in turn initiate transcription of tar-
get genes, thereby regulate cholesterol transport, uptake,
metabolism, and bile acid synthesis in the liver [87,88].
FXR can recognize free or conjugated bile acid and thus
acts as an intracellular sensor of bile acid to regulate the
metabolism of bile acid in the liver. Activation of
liganded-FXR/RXR promotes bile acid efflux and inhi-
bits bile acid synthesis [89]. PPAR is a lipid sensing
nuclear receptor, recognizing a wide range of fatty acids
[90]. These interactions between LXR, FXR, PPAR, and
RXR reflect the complexity of RXR functions and their
potentials on the RA signaling. In addition, not only do
RXRs take part promiscuously in multiple signaling
pathways, the expression of these nuclear receptors is
also under control of complex feedback loops and cross-
talks with other signaling pathways [91]. The heterodi-
merization of RXR with RAR, LXR, FXR, or PPAR is
therefore mutually competitive, and atRA signaling not
only triggers the transcription of its target genes, but
also competitively suppresses the transcription of others.
This may explain the board spectrum of atRA-induced
teratogenicity observed in embryos.
4. Differential expression and gene regulation of
RA metabolic enzymes
The RA metabolic enzymes show distinct differential
expression pattern during early embryonic development,
and interestingly their expression is regulated by the RA
signaling. Detailed descriptions of the expression pat-
terns of these genes are beyond the scope of this review.
Schematic drawing of expression of rdh10, dhrs3,
raldh2, cyp26a1, rara2, and crabp-II at Xenopus gastrula
(stage 11) and neurula (stage 14) stages are illustrated in
Figure 3, which shows that the RA signaling itself regu-
lates expression of the enzymes for RA biosynthesis and
elicits the complexity of RA acting as a morphogen in
early embryonic development. Ectopic cyp26 expression
can be induced by atRA treatment [92], while the
embryos treated with atRA showed down-regulation of
raldh2 [38] and rdh10 [46]. Dhrs3 can also be induced
by atRA treatment (RKT Kam, Y Chen, WY Chan and
H Zhao. Dhrs3 attenuates the retinoic acid signaling
and is required for early embryonic patterning. Sub-
mitted). Thus the RA signaling down-regulates the
expression of the enzymes for atRA production, but up-
regulates enzymes that can reduce atRA level in
embryos. Other components in the RA signaling are
also responsive to atRA treatment. For example, crabp-
II was found to be an atRA-inducible gene [93], and was
found to contain a RARE domain in its promoter region
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[94]. Similarly, rara2 was found to be inducible by atRA
treatment in leukemic cell lines [95], and in rat embryos
as well [96]. We summarize the regulation of these
genes by RA signaling in Figure 4.
5. Retinoic acid signaling during early embryonic
development
The RA signaling pathway has been implicated in var-
ious developmental processes. During early embryonic
development, retinoids act as an important morphogen
across different species from invertebrate to metazoan
including human [97,98]. It participates in regulating
various biological processes, such as apoptosis and dif-
ferentiation, and cell fate specification.
5.1 Axis formation
The RA signaling has been implicated in embryonic axis
formation as well. Evidence shows that it interacts with
Figure 3 Schematic diagram illustrating expression of the genes that are involved in RA biosynthesis and transportation at gastrula
(stage 11) and neurula (stage 14) stages of Xenopus embryos. rdh10 is expressed in the circumblastoporal region of Xenopus gastrula, and
the signals at the dorsal side form a zone extending anteriorly. At stage14, the signals are found in trunk paraxial mesoderm region [46]. rdh10 is
not expressed in the notochord. raldh2 is expressed in a form of a ring around the vegetal pole with signals more intense in the dorsal
blastpore lip. During neurula stages, raldh2 signals are mainly distributed in the trunk paraxial mesoderm, expanding ventrally [38]. rdh10 and
raldh2 display overlapping expression pattern in the trunk paraxial mesoderm, with rdh10 expressed more anteriorly than raldh2. cyp26a is
expressed in two primary domains at stage11, the posterior domain surrounding the blastopore and the anterior domain covering the anterior
part of prospective neural plate. At stage 14, the anterior cyp26a transcripts is developed into three elements corresponding to the cement
gland anlage, the mid-/hindbrain boundary, and the auditory placodes, while the posterior expression domain remains in the circumblastoporal
area, and the developing neural plate is also covered by a gradient of cyp26a signals with the highest present in posterior region [92]. The
expression domains of radlh2 and cyp26a do not overlap at gastrula and neurula stages of Xenopus embryos. rara2 is expressed in the involuting
surface layer surrounding the blastopore, and becomes stronger as the gastrulation proceeds. At stage 14, rara2 expression is expressed
predominantly in the posterior neural plate of the embryos [167]. The expression of the carbp-II is defined into an anterior and a posterior
domain at gastrula stages. In the anterior domain, Xenopus crabp-II is limited to the dorsal area which generates prospective head structures. At
the neurula stages, crabp-II is expressed in the prospective telencephalon and rhombencephalon, and the most posterior region of the embryos
[168]. The dhrs3 signals form a circumblastoporal ring which is similar to rdh10 at stage 11. The signals in the neural plate form two signaling
zones and gradually converge towards the midline, forming two signal strips extending posteriorly. In addition, dhrs3 is expressed in the
notochord at neurula stages [169]. All these drawings are shown in dorsal view and the blue color represents expression signals.
Figure 4 The RA signaling regulates expression of the
components involved in RA synthesis and transportation.
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Nodal signaling to regulate dorsoventral axis formation.
The mice embryos lacking all three Cyp26 genes dis-
played secondary body axes due to expansion of the
Nodal expression domain. In fact, the mouse Nodal
gene contains an RARE in the intron 1 that is highly
conserved among mammals [99]. Moreover, pre-gastru-
lation mouse embryos express Cyp26s but not Raldhs
suggesting that maternal RA is decreased by embryonic
Cyp26s for proper Nodal expression during embryonic
patterning [99].
In addition to the dorsoventral axis formation, cyp26
is also important for restricting the expression of poster-
ior genes during the anteroposterior patterning [100].
Experiments in zebrafish embryos indicate that reduc-
tion of atRA by ectopic cyp26 decreased the expression
of posterior genes meis3. Consistent with this, knock-
down of cyp26 led to the anterior expansion of meis3.
Interestingly, the expression of cyp26 is suppressed by
the FGF and Wnt signalings, which are involved in the
specification of posterior trunk during the gastrulation.
Thus, RA together with FGF and Wnt signalings forms
a complex regulatory network to regulate the anteropos-
terior axis formation in gastrula embryos, the cyp26
being one of the cross-talk genes linking these signaling
pathways [100].
The RALDHs and CYP26s enzymes also participate in
the anteroposterior patterning of the central nervous
system by maintaining a gradient of atRA along the axis
[101]. Global application of atRA to mouse embryos
during day 7 of gestation caused severe head deforma-
tions, such as exencephaly, microcephaly, and anence-
phaly, whereas exposure of embryos to atRA during day
8 of gestation led to severe caudal truncations reminis-
cent of the human caudal regression syndrome
[102,103]. Similar phenomena were observed with Xeno-
pus embryos as well [104-106].
Vertebrates display asymmetric placement of various
internal organs including the heart, liver, spleen, and
gut, and the asymmetric development of paired organs
such as brain hemispheres and lungs. Treatment with
RA antagonist in mouse led to randomization of heart
looping and perturbed sideness of node [107]. Applica-
tion of RA antagonist revealed that the RA signaling
sequentially controlled visceral and heart laterality [108].
On the other hand, the somites obviously avoid the
influence of signaling pathways that regulate the left-
right asymmetry. The somites, derived from the trunk
paraxial mesoderm and sequentially segmented along
the anteroposterior axis, are formed as bilaterally paired
units. However, the mice embryos that lack Raldh2
exhibited asymmetric somite formation [109], which was
due to left-right desynchronization of the segmentation
clock oscillations. Such defects were also observed in
RA deficient chick [110] and zebrafish [43]. It is
therefore postulated that the RA form a protection
zone, protecting the somite from the left-right asym-
metric signals to maintain the bilateral symmetry of
somites columns.
5.2 Neural differentiation
atRA has been known for its ability to induce neural dif-
ferentiation. During neural differentiation in early
embryonic development, the pro-neural induction factor
Neurogenin 2 (Neurog2) is required for primary sensory
neuron specification [111]. Two RARE identified in the
promoter region of mouse Neurog2 provide evidence
that atRA directly regulates the expression of Neurog2
and therefore neural differentiation [112]. In addition, it
has been shown that atRA treatment can induce pluri-
potent embryonic carcinoma stem cell line NT2 cells to
differentiate into forebrain, hindbrain, and spinal cord
neural progenitors [113], and the NT2 cells displayed
GABAergic and glutamatergic phenotype. In line with
this, mouse embryonic stem cells could be induced into
GABAergic neurons by atRA treatment in vitro [114].
These in vitro findings were also supported by an in
vivo study that knockdown of RARa abolished the effect
of atRA on dendritic growth [115]. Collectively, these
studies support the view that atRA is required for neural
differentiation in the central nervous system.
5.3 Hindbrain patterning
Vertebrate hindbrain contains seven rhombomeres. Sev-
eral Hox genes have been shown to be involved in
rhombomeres formation and/or provide positional iden-
tity to specific rhombomeres [116]. Two RAREs have
been identified in Hoxb1, one of which is located 5’ to
Hoxb1 promoter and is required for the restricted
expression in rhombomere 4 [117]. Studies in mouse
and fish embryos showed that retinoids could induce
ectopic expression of Hoxa1 and Hoxb1, which caused a
rhombomere 2 to 4 transformation [118-120]. In addi-
tion, the Hnf1b that suppressed Hoxb1 expression in
rhombomere 5 was also regulated by the RA signaling
[121,122]. Altogether, these data implicate that the RA
signaling is involved in hindbrain patterning. Indeed,
knockout mice lacking Raldh2 led to the conversion of
caudal hindbrain segments into rhombomere 4 identity
[123,124] and the same is true for RA antagonist treated
mice [109]. In chick embryos, treatment by using
increasing concentrations of RA antagonist, BMS453,
showed that successively more posterior rhombomere
boundaries required progressively higher concentration
of endogenous retinoic acid for their correct positioning
[125]. In zebrafish embryos, rhombomere 5 of the cau-
dal hindbrain is well specified but both rhombomere 4
and 5 were posteriorly expanded in the absence of RA
[42,126]. In Xenopus embryos, injection of cyp26a1
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mRNAs into one side of the embryo resulted in altera-
tions of the RA signaling at the injected side as indi-
cated by posteriorization of krox20, a transcription
factor marking the rhombomere 3 and 5 [92], whereas
increasing the RA signaling via ectopic expression of
raldh2 led to anteriorization of both midbrain and hind-
brain rhombomere identities in the expense of some
forebrain territory [38] (Figure 5). Despite this, studies
in mouse and Xenopus showed that decreased RA sig-
naling did not change the mid-/hindbrain boundary
(MHB)[41,92], which requires the orchestration of a
complex regulatory network involving the FGF, Wnt,
and Shh signalings [127]. On the contrary, the hind-
brain/spinal cord boundary seems to be specified
depending on the RA signaling. In zebrafish cyp26a1
mutant embryos, the expression domains of hoxb5a and
hoxb6a were expanded rostrally, leading to the expan-
sion of rostral spinal cord at the expense of the hind-
brain territory [128].
5.4 Pancreas
The RA signaling also plays essential roles in the regio-
nalization of endoderm as early as during gastrulation
[129]. Studies in frog, avian, and mice indicate that the
RA signaling is essential for dorsal pancreas formation,
partially required for ventral pancreas patterning
[129-134]. In zebrafish, inhibition of RA signaling before
the end of gastrulation inhibits the initial development
of both hepatic and pancreatic endoderm [135]. Evi-
dence shows that it is the RA signal emanating from
paraxial mesoderm that directly induces endocrine
pancreatic precursors in the adjacent endoderm [136].
For example, Mnx1 is identified as an RA downstream
gene that controls cell fate choice in the developing
endocrine pancreas [137]. Cyp26a1, expressed in endo-
derm, defines the anterior boundary of dorsal pancreatic
anlage by inactivating excess RA [138], while Cdx4,
expressed in posterior endoderm, acts to antagonize the
RA signaling and thus establishes the posterior bound-
ary of dorsal pancreatic territory in zebrafish embryos
(Figure 6; [139]). Moreover, Raldh1 is expressed in
developing mouse and human pancreas at stages when
mature b-cells are generated [140], suggesting the role
of RA in b-cell differentiation. The XPDIp is expressed
in the exocrine portion of both dorsal and ventral pan-
creas. Inhibition of RA signaling by BMS453 treatment
completely abolished expression of XPDIp in dorsal pan-
creas, but had mild effects on the ventral pancreas, sug-
gesting the development of dorsal pancreas is more RA
signaling dependent [129].
In addition, in vitro data have also demonstrated a
role of RA in pancreas development. In a defined in
vitro explant system, RA treatment of cultured mouse
E10.5 dorsal pancreatic buds could induce the genera-
tion of Ngn3+ endocrine progenitor cells and stimulate
their further differentiation into b-cells by activating a
differentiation program that recapitulates the normal
temporal program of b-cell differentiation [140]. In zeb-
rafish, exogenous RA led to expansion of both exo- and
endocrine cells, while in Xenopus embryos as well as
cultured mouse embryonic pancreatic rudiments, exo-
genous RA led to an expansion of the endocrine cell
population at the expense of the exocrine cells in the
Figure 5 Schematic diagram of krox20 expression in control
embryos (A), and in embryos with alterated RA signaling (B, C).
Alternation of RA gradient induces shift of the expression domain of
krox20. The expression of krox20 labels rhombomeres 3 and 5 (A,
yellow). Co-injection of lacZ and cyp26 or rdh10 or rdh2 mRNA into
one blastomere of two-cell stage Xenopus embryos is indicated by
LacZ staining (B, C, blue). The uninjected side is served as control.
Ectopic cyp26 at one side of the embryos causes posterior shift of
krox20 (B, yellow). In contrast to cyp26, overexpression of rdh10 and
radlh2 leads to anterior shift of krox20 (C, yellow). This diagram is
based on the previous reports and our unpublished data [46,92,129]
(RKT Kam, Y Chen, WY Chan and H Zhao. Dhrs3 attenuates the
retinoic acid signaling and is required for early embryonic
patterning. Submitted.).
Figure 6 RA plays an essential role in dorsal pancreas
specification. During gastrulation and early neurulation, the field in
dorsal endoderm that gives rise to the presumptive dorsal pancreas
is just underlying the dorsal mesoderm where the highest
concentration of RA is generated. These RA signals can act to
underly endoderm either directly, or indirectly via first activating
unknown factors (Xs) in mesoderm, which then act on the
endoderm for dorsal pancreas formation. As described in the text,
Shh and Cyp26a1 expressed in more anterior dorsal endoderm block
pancreas formation probably via inhibiting the RA signaling activity
or directly degrading RA. Cdx4 expressed in the posterior dorsal
endoderm helps to establish the posterior boundary of dorsal
pancreas via antagonizing the RA signaling.
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dorsal pancreas [129,141,142]. Similarly, the induction of
pancreatic fate by RA in endodermalized naive ectoderm
dissected from early Xenopus gastrulae only showed the
generation of early insulin-expressing cells [143,144].
Therefore, cautions should be taken to apply RA at the
right time and the right dose (close to physiological con-
centration in early embryos) for in vitro induction of
mature pancreatic b-cells from embryonic stem cells.
5.5 Heart
The effect of RA on cardiogenesis was first demon-
strated in quail that vitamin A deficiency could induce
defective primitive heart development [145]. Further evi-
dence shows that RA signaling is required for the for-
mation of cardiac progenitors [146], and the correct
modeling of the early heart field and the anteroposterior
patterning of the heart is controlled by atRA through
the action of Isl1 and Fgf8 signaling pathway [147,148].
Knockout mice embryos lacking Raldh2 showed an
abnormal development of the second heart field (SHF)
[149], which is a population of undifferentiated cardiac
precursor cells originating from the pharyngeal meso-
derm and lying medial to the cardiac crescent (the first
heart field). The expression of SHF markers including
Isl1, Tbx1, and Fgf8, was posteriorly expanded in these
embryos [150], indicating that the RA signaling is
required for the restriction of SHF. Defects in the for-
mation of a proper heart tube might also partially
explain why Raldh2-/- is embryonic lethal [148]. Studies
in zebrafish indicated RA functions in the restriction of
cardiac specification [149]. During this process, if RA
signaling was inhibited in lateral mesoderm, the uncom-
mitted cells could differentiate into myocardial progeni-
tor cells instead of pharyngeal or pancreatic cells [149],
leading to the expansion of cardiomyocytes.
In addition to the heart development, the RA signaling
has also been implicated in heart regeneration in adult
zebrafish. Gene profiling assay indicated that raldh2 was
one of the most highly induced genes in the regenerat-
ing heart [151]. After the ventricular injury, raldh2 was
activated in the endocardium, but its expression was
subsequently restricted in endocardial cells at the injury
site one day post-trauma as the repairing cardiogenesis
began. By 7 days after amputation, the epicardial cells at
the injury site also expressed raldh2. Inhibition of RARs
or expression of an RA-degrading enzyme blocked
regenerative cardiomyocyte proliferation [152]. These
findings reveal essential roles of RA in repairing the
damaged heart tissue and promoting cardiomyocyte
proliferation.
5.6 Kidney
There is increasing evidence indicating that atRA plays
important roles in kidney development [153-155]. The
kidney field is derived from the intermediate mesoderm.
The specification of renal progenitor cells is influenced
by RA signals emanating from the paraxial mesoderm
[153-155]. Recent studies in Xenopus and zebrafish have
demonstrated that ectopic production of RA increased
the size of the kidney field, while blocking the pathway
inhibited the kidney specification [86,154]. In Xenopus,
pax8 and lhx1,which are the earliest determinants of
pronephric fate are both under control of the RA signal-
ing [154,156], while pteg, an early pronephric marker, is
a direct target of the RA signaling and an essential fac-
tor for pronephric specification [157]. Another critical
factor for the pronephros development, Wilm’s tumor
suppressor (wt1), is under direct control of the RA sig-
naling as well [158,159]. Inhibition of RA by BMS453
treatment caused reduction of pronephros field, as
revealed by the decreased expression of the pronephros
markers including smp-30 and pax2 at the late tailbud
stage [154]. Furthermore, in Xenopus embryos, the pluri-
potent animal cap cells treated with RA and activin
could differentiate into pronephros tissue [154,160].
Likewise, the RA signaling is also essential for directing
the proximodistal patterning of pronephric nephron in
zebrafish [161]. The exogenous RA could induce proxi-
mal segment fates at the expense of distal fates, whereas
inhibition of the RA signaling caused a loss of the proxi-
mal segments and an expansion of the distal segments.
Interestingly, inactivation of both RARa and RARb in
mice embryos resulted in renal malformations [155].
Further evidence showed that RARa and RARb were co-
expressed with Ret, a receptor tyrosine kinase involved
in renal development, in renal stromal mesenchyme,
where their deletion led to altered stromal cell pattern-
ing, impaired ureteric bud growth, and down-regulation
of Ret in the ureteric bud. Moreover, studies in mice
indicate that the RA signaling in ureteric bud cells
mainly depends on atRA generated through Raldh2 in
stromal cells [162].
5.7 Lung
Evidence indicates that disruption of the RA signaling
during early development caused abnormalities of lung
formation. Either knockout of Raldh2 or treatment with
BMS 493, a RA inhibitor, caused defects of lung forma-
tion in mice [163]. During primary lung bud morpho-
genesis, although RA is not required for specification of
lung cell fate in the endoderm, it is essential for the
induction of the primordial lung buds [163,164]. During
the induction of lung bud, the RA signaling inhibits the
expression of Dkk-1, the Wnt signaling inhibitor, in the
foregut mesoderm. This inhibition in turn activates Wnt
signaling in the lung bud region. At the same time, the
RA signaling also inhibits TGF-b signaling. The
balanced Wnt and TGF-b signalings coordinate with
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each other to induce and maintain the optimal expres-
sion level of Fgf10 for the induction of the lung primor-
dium [165]. Furthermore, airway branching was
accompanied by down-regulation of the RA signaling
pathway [166], thus regional mechanisms that control
RA availability and utilization are important for the lung
morphogenesis.
Concluding remarks
To date, it has been demonstrated that the RA signaling
plays sophisticated roles in early embryonic develop-
ment. In fact, gastrulation is a very critical period for
the RA signaling to exert its function in the regionaliza-
tion of all three germ layers along the anteroposterior
axis. RA is mainly generated in the mesoderm and thus
can be most efficiently used. It is not clear as to how
the RA metabolic enzymes coordinate with each other
to generate the RA gradient at right time, right region,
and with right strength during early embryonic develop-
ment. Future studies are needed to identify the immedi-
ate and direct RA target genes in distinct RA responsive
cells and to define the crosstalks between RA and other
signaling pathways, such as hedgehog, FGF, Wnt, and
Notch signalings for the formation and regionalization
of three germ layers. Such knowledge will be essential
for understanding organogenesis and establishing reli-
able strategies for stem cell differentiation into specific
cell types that can be used for treatment of human
diseases.
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